Mowery & Schoenfeld Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.3K Hold
113
0.02% 213
2026
Q1
$15.7K Sell
113
-68
-38% -$9.52K 0.02% 187
2025
Q4
$22.2K Buy
181
+68
+60% +$8.26K 0.03% 187
2025
Q3
$12.5K Hold
113
0.02% 203
2025
Q2
$12.5K Hold
113
0.02% 203
2025
Q1
$12.7K Sell
113
-3
-3% -$310 0.02% 245
2024
Q4
$10.7K Buy
116
+28
+32% +$2.52K 0.02% 223
2024
Q3
$7.38K Sell
88
-160
-65% -$12.2K 0.01% 186
2024
Q2
$17K Buy
+248
New +$16.6K 0.02% 150

Other funds holding GILD

Mowery & Schoenfeld Wealth Management's GILD Position: Q2 2026 in Review

Mowery & Schoenfeld Wealth Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 113 shares worth $14.3K. The position accounts for 0.02% of the portfolio, ranked #213.

Mowery & Schoenfeld Wealth Management first reported a position in GILD in Q2 2024 and has held it in 9 quarters since. The position peaked at $22.2K in Q4 2025. 1,509 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Mowery & Schoenfeld Wealth Management held 113 shares of Gilead Sciences worth $14.3K as of Q2 2026.
  • Mowery & Schoenfeld Wealth Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.02% of Mowery & Schoenfeld Wealth Management's portfolio in Q2 2026, its #213 holding.
  • Mowery & Schoenfeld Wealth Management first reported a position in Gilead Sciences in Q2 2024 and has held it in 9 quarters since.
  • Mowery & Schoenfeld Wealth Management's Gilead Sciences position peaked at $22.2K in Q4 2025.
  • 1,509 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Mowery & Schoenfeld Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.